Health Care Costs and Utilization of Dabigatran Compared with Warfarin for Secondary Stroke Prevention in Patients with Nonvalvular Atrial Fibrillation

Nai Fang Chi, Ye Wang, Li Nien Chien, Shu Chen Chien, Yu Ko*

*此作品的通信作者

研究成果: Article同行評審

2 引文 斯高帕斯(Scopus)

指紋

深入研究「Health Care Costs and Utilization of Dabigatran Compared with Warfarin for Secondary Stroke Prevention in Patients with Nonvalvular Atrial Fibrillation」主題。共同形成了獨特的指紋。

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology